Celgene Corporation Reviews 2008 Achievements and Announces 2009 Financial Outlook.
Business Wire › January 12, 2009
Linked as:
Extract
Celgene Corporation Reviews 2008 Achievements and Announces 2009 Financial Outlook.
Significant Fourth Quarter Growth Propels REVLIMID([R]) to the Global Market Leader in Multiple Myeloma
SUMMIT, N.J. -- Exceptional 2008 Operating Performance Exceeding Annual Guidance with Record Revenue and Profit Growth * Total Revenue for 2008 Increased to Approximately $2.233 Billion (Unaudited) * REVLIMID Net Product Sales in 2008 Increased More Than 71 Percent Year-Over-Year to Approximately $1.324 Billion (Unaudited) * REVLIMID Net Product S...See the full content of this document
Sponsored links
